These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression. Abounader R, Ranganathan S, Lal B, Fielding K, Book A, Dietz H, Burger P, Laterra J. J Natl Cancer Inst; 1999 Sep 15; 91(18):1548-56. PubMed ID: 10491431 [Abstract] [Full Text] [Related]
4. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy. Li Y, Lal B, Kwon S, Fan X, Saldanha U, Reznik TE, Kuchner EB, Eberhart C, Laterra J, Abounader R. Cancer Res; 2005 Oct 15; 65(20):9355-62. PubMed ID: 16230398 [Abstract] [Full Text] [Related]
5. Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma. Papa E, Weller M, Weiss T, Ventura E, Burghardt I, Szabó E. Cell Death Dis; 2017 Dec 13; 8(12):3210. PubMed ID: 29238047 [Abstract] [Full Text] [Related]
6. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth. Cai W, Rook SL, Jiang ZY, Takahara N, Aiello LP. Invest Ophthalmol Vis Sci; 2000 Jun 13; 41(7):1885-93. PubMed ID: 10845613 [Abstract] [Full Text] [Related]
7. Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor. Ried S, Jäger C, Jeffers M, Vande Woude GF, Graeff H, Schmitt M, Lengyel E. J Biol Chem; 1999 Jun 04; 274(23):16377-86. PubMed ID: 10347197 [Abstract] [Full Text] [Related]
8. Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways. Xiao GH, Jeffers M, Bellacosa A, Mitsuuchi Y, Vande Woude GF, Testa JR. Proc Natl Acad Sci U S A; 2001 Jan 02; 98(1):247-52. PubMed ID: 11134526 [Abstract] [Full Text] [Related]
9. Transcriptional activation of the hepatocyte growth factor receptor (c-met) gene by its ligand (hepatocyte growth factor) is mediated through AP-1. Seol DW, Chen Q, Zarnegar R. Oncogene; 2000 Feb 24; 19(9):1132-7. PubMed ID: 10713700 [Abstract] [Full Text] [Related]
10. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1. Recio JA, Merlino G. Oncogene; 2002 Feb 07; 21(7):1000-8. PubMed ID: 11850817 [Abstract] [Full Text] [Related]
11. Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP. Hamasuna R, Kataoka H, Moriyama T, Itoh H, Seiki M, Koono M. Int J Cancer; 1999 Jul 19; 82(2):274-81. PubMed ID: 10389763 [Abstract] [Full Text] [Related]
12. Mitogenic synergy through multilevel convergence of hepatocyte growth factor and interleukin-4 signaling pathways. Day RM, Soon L, Breckenridge D, Bridges B, Patel BK, Wang LM, Corey SJ, Bottaro DP. Oncogene; 2002 Mar 28; 21(14):2201-11. PubMed ID: 11948403 [Abstract] [Full Text] [Related]
13. PKC, p42/44 MAPK and p38 MAPK regulate hepatocyte growth factor secretion from human astrocytoma cells. Chattopadhyay N, Tfelt-Hansen J, Brown EM. Brain Res Mol Brain Res; 2002 Jun 15; 102(1-2):73-82. PubMed ID: 12191496 [Abstract] [Full Text] [Related]
14. A natural hepatocyte growth factor/scatter factor autocrine loop in myoblast cells and the effect of the constitutive Met kinase activation on myogenic differentiation. Anastasi S, Giordano S, Sthandier O, Gambarotta G, Maione R, Comoglio P, Amati P. J Cell Biol; 1997 Jun 02; 137(5):1057-68. PubMed ID: 9166406 [Abstract] [Full Text] [Related]
15. Hepatocyte growth factor signal coupling to various transcription factors depends on triggering of Met receptor and protein kinase transducers in human hepatoma cells HepG2. Tacchini L, Dansi P, Matteucci E, Desiderio MA. Exp Cell Res; 2000 Apr 10; 256(1):272-81. PubMed ID: 10739674 [Abstract] [Full Text] [Related]
16. Neuroprotection by scatter factor/hepatocyte growth factor and FGF-1 in cerebellar granule neurons is phosphatidylinositol 3-kinase/akt-dependent and MAPK/CREB-independent. Hossain MA, Russell JC, Gomez R, Laterra J. J Neurochem; 2002 Apr 10; 81(2):365-78. PubMed ID: 12064484 [Abstract] [Full Text] [Related]
17. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1. Recio JA, Merlino G. Cancer Res; 2003 Apr 01; 63(7):1576-82. PubMed ID: 12670907 [Abstract] [Full Text] [Related]
18. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma. Price JA, Kovach SJ, Johnson T, Koniaris LG, Cahill PA, Sitzmann JV, McKillop IH. Hepatology; 2002 Nov 01; 36(5):1089-97. PubMed ID: 12395318 [Abstract] [Full Text] [Related]
19. Selective activation of phospholipase C gamma1 and distinct protein kinase C subspecies in intracellular signaling by hepatocyte growth factor/scatter factor in primary cultured rat neocortical cells. Machide M, Kamitori K, Nakamura Y, Kohsaka S. J Neurochem; 1998 Aug 01; 71(2):592-602. PubMed ID: 9681449 [Abstract] [Full Text] [Related]
20. Increase in hepatocyte growth factor receptor tyrosine kinase activity in renal carcinoma cells is associated with increased motility partly through phosphoinositide 3-kinase activation. Nakamura T, Kanda S, Yamamoto K, Kohno T, Maeda K, Matsuyama T, Kanetake H. Oncogene; 2001 Nov 15; 20(52):7610-23. PubMed ID: 11753639 [Abstract] [Full Text] [Related] Page: [Next] [New Search]